Skip to main content
Erschienen in: Pediatric Cardiology 7/2022

Open Access 09.04.2022 | Original Article

Pulse Wave Velocity Measurements by Magnetic Resonance Imaging in Neonates and Adolescents: Methodological Aspects and Their Clinical Implications

verfasst von: Simon Lundström, Jonas Liefke, Einar Heiberg, Erik Hedström

Erschienen in: Pediatric Cardiology | Ausgabe 7/2022

Abstract

Pulse wave velocity (PWV) by cardiovascular magnetic resonance (CMR) lacks standardization. The aim of this study was to investigate methodological aspects of PWV measurements by CMR in neonates and adolescents. A computer phantom was created to validate the temporal resolution required for accurate PWV. Fifteen neonates and 71 adolescents underwent CMR with reference standard 3D angiography and phase-contrast flow acquisitions, and in a subset coronal overview images. Velocity and flow curves, transit time methods (time-to-foot (TTF), maximum upslope, and time-to-peak (TTP)), and baseline correction methods (no correction, automatic and manual) were investigated. In neonates, required timeframes per cardiac cycle for accurate PWV was 42 for the aortic arch and 41 for the thoracic aorta. In adolescents, corresponding values were 39 and 32. Aortic length differences by overview images and 3D angiography in adolescents were − 16–18 mm (aortic arch) and − 25–30 mm (thoracic aorta). Agreement in PWV between automatic and manual baseline correction was − 0.2 ± 0.3 m/s in neonates and 0.0 ± 0.1 m/s in adolescents. Velocity and flow-derived PWV measurements did not differ in either group (all p > 0.08). In neonates, transit time methods did not differ (all p > 0.19) but in adolescents PWV was higher for TTF (3.8 ± 0.5 m/s) and maximum upslope (3.7 ± 0.6 m/s) compared to TTP (2.7 ± 1.0 m/s; p < 0.0001). This study is a step toward standardization of PWV in neonates and adolescents using CMR. It provides required temporal resolution for phase-contrast flow acquisitions for typical heartrates in neonates and adolescents, and supports 3D angiography and time-to-foot with automatic baseline correction for accurate PWV measurements.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CMR
Cardiovascular magnetic resonance
PWV
Pulse wave velocity
TTF
Time-to-foot
TTP
Time-to-peak

Background

Arterial stiffness is a predictor for long-term cardiovascular disease [1]. Pulse wave velocity (PWV) is an established surrogate marker for arterial stiffness and an independent predictor of cardiovascular mortality and morbidity [1, 2]. Whereas carotid-femoral applanation tonometry is commonly used for measuring PWV, this method lacks in precision. Cardiovascular magnetic resonance (CMR) imaging agrees with invasive measurements of PWV but is limited by lack of standardization [39]. More specifically, required temporal resolution, flow plane locations, use of baseline correction, and applied PWV curve analysis methods differ between studies [1, 610]. Differences in PWV values may thus be due to both physiological and methodological differences, which limits comparison between studies and clinical use of reference values.
Dorniak et al. [6] showed that the required temporal resolution for PWV measurements in adults is 35 timeframes per cardiac cycle, corresponding to a temporal resolution of 30 ms. Required temporal resolution for children is however unknown. Additionally, it is unclear whether standard CMR coronal overview images acquired as part of a routine CMR examination are sufficient in resolution for measuring aortic length or whether the more accurate reference standard for vessel length assessment, 3D angiography, is required. The lack of standardization limits clinical applicability and particularly complicates comparison of data between centers.
The overall aim of this study was therefore to investigate methodological aspects of PWV measurements by CMR, as a means toward standardization in neonates and adolescents. Specifically, the aims were to investigate (1) the required temporal resolution of phase-contrast flow data for accurate PWV measurements for different aortic lengths using a computer phantom; (2) impact on PWV using standard coronal overview images and non-contrast-enhanced 3D angiography for centerline vessel length; (3) velocity-based and flow-based curves for PWV; (4) impact on PWV using different transit time methods; and (5) impact of baseline correction on PWV.

Materials and Methods

Study Population and Protocol

Data from 15 prospectively included neonates and 71 adolescents who underwent cardiovascular magnetic resonance imaging at Skåne University Hospital between 2014 and 2020 were used. An additional adolescent was included for computer phantom construction and was not further incorporated in analyses. The regional Ethics Review Board (Lund, Sweden) approved the study. All participants, and their guardians when appropriate, provided written informed consent before participation in the study.

Computer Phantom

The pulse wave velocity computer phantom methodology from Dorniak et al. [6] was used to establish the required temporal resolution needed for accurate PWV measurements. Phantom vessel lengths were set to approximately the minimum vessel lengths of the current populations, i.e., 25 mm for neonates’ aortic arch, 60 mm for neonates’ thoracic aorta and adolescents’ aortic arch, and 150 mm for adolescents’ thoracic aorta. Post-acquisition analysis of the study population revealed sufficient timeframes per cardiac cycle for construction of a high-resolution computer phantom for neonates, but not for adolescents. This was due to a limitation in reconstructed number of timeframes. As a result, one additional adolescent (17-year-old female, 162 cm, 55 kg) was included and used for the phantom construction only. Computer phantoms with a reference pulse wave velocity between 2 and 10 m/s were generated to cover the normal pulse wave velocity interval for neonates and adolescents [11], while also including large margins for potential confounders. A representative high-resolution ascending flow curve from each group was upsampled to 10,000 timeframes per cardiac cycle. A simulated corresponding descending flow curve was created by shifting the ascending flow curve in time with a delay computed as the vessel length (aortic arch or thoracic aorta) divided by the reference PWV (i.e., 2 m/s, 4 m/s, 6 m/s, 8 m/s, 10 m/s). Thereafter the descending flow curve was scaled in amplitude with 60% to mimic the blood diversion to the aortic arch branches and finally smoothed with a Gaussian smoothing filter with a width of 2,000 timeframes. The flow profile was then downsampled to 20–60 timeframes per cardiac cycle to mimic image acquisition with different temporal resolutions. For each combination of reference PWV and timeframes per cardiac cycle, the PWV was calculated using the TTF method on the downsampled ascending and descending flow curves and compared to the reference PWV. Differences were presented as % error. The full code for the phantom can be found as part of the open source code distribution for the software Segment.

Pulse Wave Velocity by CMR in Neonates and Adolescents

Participants were imaged in supine position using a 1.5 T MR scanner (Philips Achieva, Best, the Netherlands, or Siemens Aera, Erlangen, Germany). For adolescents a 32-channel phased-array cardiac coil (Philips) or 18-channel and spine coil combination (Siemens) was used according to clinical routine. For neonates a small flexible coil was chosen. Further, neonates were positioned in a vacuum infant immobilizer and either imaged using feed-and-sleep or if this was not possible, using chloral hydrate 25 mg/kg administered rectally. A 2D phase-contrast gradient recalled echo sequence with retrospective ECG gating was used for quantitative flow measurements. For both neonates and adolescents, two phase-contrast flow planes were acquired; one positioned in the ascending aorta as part of the clinical standard protocol which also includes the descending aorta immediately after the aortic arch, albeit potentially angulated to the vessel, and one at the level of the diaphragm. For aortic length measurements in adolescents, 3D oblique sagittal slices covering the thoracic aorta (non-contrast enhanced 3D angiography) and coronal slices covering the entire thorax (coronal overview) were acquired. A subset of adolescents (n = 49) had both 3D non-contrast-enhanced angiography and thoracic coronal overview images acquired for comparison of aortic length measurements. The coronal overview images were based on a balanced SSFP sequence with inplane resolution 1.66 mm and slice thickness 8 mm and slice gap 2.64 mm, whereas the 3D angiography was based on a clinical routine T2-prepared balanced steady-state free precession sequence with isotropic resolution 0.88 mm (Philips) or 0.55 mm (Siemens). In neonates a clinical routine 3D black-blood T1-weighed non-contrast-enhanced angiography sequence was used with isotropic resolution 1.04 mm (Siemens). Typical image parameters for the quantitative flow phase-contrast sequence were TR/TE 4.92/2.67 ms, flip angle 20°, 1.5 × 1.5 × 5 mm3 (Siemens) for neonates. Corresponding parameters for adolescents were TR/TE 9.15/5.54 ms, flip angle 15°,1.2 × 1.2 × 6 mm3 (Philips); and TR/TE 4.92/2.67 ms, flip angle 20°, 1.5 × 1.5 × 5 mm3 (Siemens). Reconstruction was set to a maximum of 50 timeframes per cardiac cycle for neonates and 35 for adolescents. In the one adolescent scanned for construction of the computer phantom, flow data were collected using the Siemens scan protocol but with the reconstruction limit set at 70 timeframes per cardiac cycle to avoid assessment errors. Velocity encoding was 150–250 cm/s to optimize velocity resolution and avoid aliasing. Temporal resolution (ms) was calculated as heartrate duration divided by timeframes per cardiac cycle.
Image analysis was performed using the software Segment version 3.2 R9405 (http://​segment.​heiberg.​se, Medviso AB, Lund, Sweden) [12]. Three observers assessed velocity and volumetric flow curves in the ascending aorta, descending aorta after the aortic arch and at the level of the diaphragm, and length measurements in the aortic arch and thoracic aorta. The observers had 2 years’ (observer 1, assessed coronal overview data; SL), 5 years’ (observer 2, assessed 3D angiography data and flow data; JL), and 21 years’ (confirmed data from observer 1 and observer 2; EHed) CMR experience. A subset of 15 data sets (5 neonates and 10 adolescents) were randomly chosen and delineated by observers 1 and 2 for interobserver assessment. Aortic arch and thoracic aorta lengths by 3D angiography were used for length comparison between observers and the PWV method with least bias and variability was used for transit time comparisons.
Vessel length (Δd), i.e., blood traveling distance between flow planes, was measured in the reference standard 3D angiography images and in 2D coronal overview images. For both image types a manual frame-by-frame centerline vessel tracking method was used (Fig. 1). Lengths reported are from the reference standard 3D angiography unless otherwise specified.
Velocity and flow curves were assessed using automatic segmentation with manual correction where needed [12] with vessel circumference delineated throughout the cardiac cycle in magnitude images supported by phase-contrast images as appropriate and analyzed according to Dorniak et al. [6] for PWV (Fig. 2).
Three transit time (Δt) methods were compared as shown in Fig. 3; namely (1) time-to-foot (TTF), (2) maximum upslope, and (3) time-to-peak (TTP). The algorithms were based on the baseline intersection of an automatically generated tangent superimposed at the point of maximum upslope (TTF); the maximum upslope incline (maximum upslope), and the maximum curve magnitude (TTP). For TTF, which is baseline dependent, baseline correction was applied both automatically and manually. For automatic baseline correction, a modified version of the algorithm previously described by Dorniak et al. [6] was applied, using instead the mean of the 80th–95th % segment of the flow curves (Fig. 4). For manual correction, this study instead proposed to use the segment prior to the systolic upslope, to avoid errors related to the diastolic phase of the cardiac cycle such as backward flow related to insufficiency. Gaussian smoothing was performed on all curves to optimize signal-to-noise ratio with sigma = 0.025. Pulse wave velocity was calculated as PWV = traveling distance (Δd) / transit time (Δt).

Statistical Analyses

Statistical analyses were performed in GraphPad 9.2.0 for Windows (GraphPad Software, La Jolla, California, USA). Group characteristics and vessel lengths were not normally distributed and presented as median (range), whereas PWV comparisons were normally distributed and therefore presented as mean ± SD. Bland–Altman plots assessed agreement between methods with data presented as bias ± SD in text and bias and 95% limits of agreement (LoA; i.e., ± 1.96 SD) in graphs. Intra-individual variations between coronal overview images and the reference standard 3D angiography are presented as median and 2.5th–97.5th percentile. Interobserver variabilities are presented as mean ± SD. Paired t-test or repeated-measures ANOVA with Tukey correction post hoc assessed group differences. P values < 0.05 were considered to indicate statistically significant differences.

Results

Computer Phantom

Figure 5 shows the computer phantom results as timeframes per cardiac cycle, independent of heart rate. For a neonatal flow curve profile and an aortic length > 25 mm (i.e., shortest neonatal aortic arch), 42 timeframes per cardiac cycle resulted in a PWV error range of − 8–2%, and for an aortic length > 60 mm (i.e., shortest neonatal thoracic aorta) 41 timeframes per cardiac cycle resulted in a PWV error range of − 6–1%. Corresponding number of timeframes for an adolescent flow profile and aortic length > 60 mm (i.e., shortest adolescent aortic arch) and for an aortic length > 150 mm (i.e., shortest adolescent thoracic aorta) were 39 timeframes per cardiac cycle (PWV error range − 8–3%) and 32 timeframes per cardiac cycle (PWV error range − 4–6%), respectively. Fewer timeframes per cardiac cycle and particularly so combined with higher PWV and shorter pulse wave traveling distance yielded larger errors, with neonatal aortic arch showing the largest PWV error of approximately 30% at 33 timeframes per cardiac cycle and a PWV of 8 m/s.

Pulse Wave Velocity by CMR in Neonates and Adolescents

Table 1 shows group characteristics for neonates and adolescents. Reconstructed timeframes per cardiac cycle was 44 in neonates, corresponding to a temporal resolution of 10 ms for an average heart rate of 138 bpm, and 35 in adolescents corresponding to a temporal resolution of 22 ms for an average heart rate of 75 bpm.
Table 1
Group characteristics for neonates and adolescents
 
Neonates
Adolescents
Participants (females)
15 (47%)
71 (51%)
Age (neonates: days; adolescents: years)
14 (6–45)
14 (13–17)
Weight (kg)
3.3 (2.8–6.5)
56 (37–90)
Height (cm)
50 (45–58)
165 (148–189)
Aortic arch length (mm)
30 (23–59)
86 (62–124)
Thoracic aortic length (mm)
68 (55–83)
188 (149–258)
Heart rate (beats per minute)
138 (108–160)
75 (44–128)
Absolute values (%) and median (range)

Aortic Lengths

Figure 6 shows vessel length measurements and agreement. In neonates the median aortic centerline length by 3D angiography was 30 (23–59) mm for the aortic arch and 68 (55–83) mm for the thoracic aorta. In adolescents, the median aortic arch length was 86 (62–124) mm by the reference standard 3D angiography and 88 (64–113) mm by overview images (p = 0.09), and median thoracic aortic length was 188 (149–258) mm by the reference standard and 195 (153–245) mm by overview images (p < 0.0001). Variations between the reference standard 3D angiography and coronal overview images were − 16–18 mm for aortic arch length and − 25–30 mm for thoracic aortic length. Interobserver variability for 3D angiography length measurements for neonates and adolescents combined were – 2 ± 2 mm.

Impact of Baseline Correction on PWV

Figure 7A shows agreement between baseline correction methods for thoracic aorta PWV in neonates. Pulse wave velocity bias between automatic and manual baseline correction was – 0.2 ± 0.2 m/s for velocity curves and − 0.2 ± 0.3 m/s for flow curves. Corresponding bias was 0.5 ± 0.7 m/s and 0.5 ± 0.6 m/s for manual and no baseline correction and 0.6 ± 0.7 m/s and 0.7 ± 0.5 m/s for automatic and no baseline correction.
Figure 7B shows agreement between baseline correction methods for thoracic aorta PWV in adolescents. Pulse wave velocity bias between automatic and manual baseline correction was 0.0 ± 0.2 m/s for velocity curves and 0.0 ± 0.1 m/s for flow curves. Corresponding bias was 0.5 ± 0.3 m/s and 0.4 ± 0.2 m/s for manual and no baseline correction and 0.5 ± 0.3 m/s and 0.4 ± 0.2 m/s for automatic and no baseline correction.
Table 2 shows thoracic aorta PWV differences related to baseline correction methods. In neonates, velocity-based PWV by TTF with no baseline correction was higher (4.8 ± 1.6 m/s) than with automatic baseline correction (4.2 ± 1.0 m/s) (p = 0.01). In adolescents, PWV was higher using both velocity and flow curves for TTF with no baseline correction (4.4 ± 0.6 m/s and 4.2 ± 0.5 m/s) compared with automatic (3.9 ± 0.5 m/s and 3.8 ± 0.5 m/s) and manual baseline correction (3.9 ± 0.5 m/s and 3.8 ± 0.4 m/s; all p < 0.0001). Further, velocity-based PWV by TTF with no baseline correction was higher (4.4 ± 0.6 m/s) than the corresponding flow-based PWV (4.2 ± 0.5 m/s) (p < 0.001).
Table 2
Pulse wave velocity (m/s) differences related to baseline correction methods
 
Velocity
Flow
p value
Neonates
   
 No baseline correction
4.8 ± 1.6
4.8 ± 1.3
 > 0.99
 Automatic baseline correction
4.2 ± 1.0*
4.1 ± 0.9
 > 0.99
 Manual baseline correction
4.3 ± 1.1
4.3 ± 0.9
 > 0.99
Adolescents
   
 No baseline correction
4.4 ± 0.6
4.2 ± 0.5
 < 0.0001
 Automatic baseline correction
3.9 ± 0.5***
3.8 ± 0.5***
0.07
 Manual baseline correction
3.9 ± 0.5***
3.8 ± 0.4***
0.76
All values are based on thoracic aorta measurements and the time-to-foot algorithm. Mean ± SD
*p < 0.05 compared to no baseline correction
*** p < 0.0001 compared to no baseline correction

Impact of Transit Time Methods on PWV

Figure 8 shows transit time method comparisons. In neonates, thoracic aorta PWV based on velocity curves were 4.2 ± 1.0 m/s for TTF, 6.1 ± 2.4 m/s for maximum upslope, and 1.8 ± 5.4 m/s for TTP. Corresponding PWV based on flow curves were 4.1 ± 0.9 m/s, 6.4 ± 3.5 m/s, and 5.3 ± 5.6 m/s.
In adolescents, thoracic aorta PWV based on velocity curves were 3.9 ± 0.5 m/s for TTF, 3.8 ± 0.6 m/s for maximum upslope, and 2.6 ± 0.8 m/s for TTP. Corresponding PWV based on flow curves were 3.8 ± 0.5 m/s, 3.7 ± 0.6 m/s, and 2.7 ± 1.0 m/s. Time-to-peak thus yielded lower PWV than maximum upslope (p < 0.0001) and TTF (p < 0.0001) for both velocity and flow curves in adolescents.
Figure 9 shows agreement between thoracic aorta velocity and flow curves for each transit time method. Time-to-foot yielded PWV 0.0 ± 0.4 m/s for neonates and − 0.1 ± 0.2 m/s for adolescents. Corresponding values were for maximum upslope 0.3 ± 1.8 m/s and − 0.1 ± 0.4 m/s, and for TTP 3.5 ± 8.2 m/s and 0.1 ± 0.7 m/s.

Pulse Wave Velocities

Figure 10 shows neonatal and adolescent PWV based on TTF with automatic baseline correction. Neonatal PWV based on centerline distance by 3D angiography was 2.8 ± 1.0 m/s for the aortic arch and 4.1 ± 0.9 m/s for the thoracic aorta. Adolescents’ aortic arch PWV was 4.3 ± 1.1 m/s based on centerline distance by 3D angiography and 4.4 ± 1.2 m/s when centerline distance was based on coronal overview images (p = 0.08). Corresponding values for adolescents’ thoracic aorta PWV were 3.8 ± 0.4 m/s and 3.9 ± 0.5 m/s (p < 0.0001). Variation in adolescents’ PWV derived from coronal overview and 3D angiography length measurements was more prominent (− 0.8–1.1 m/s) for the aortic arch than for the thoracic aorta (− 0.3–0.6 m/s). Interobserver variability for flow PWV by TTF with automatic baseline correction was 0.0 ± 0.1 m/s, corresponding to an error of − 1 ± 2%.

Discussion

This study showed how methodological aspects influence PWV values by CMR in neonates and adolescents. The differences in measured PWV values confirm the hypothesis that measurement methods cannot be used interchangeably. This in turn limits comparability between existing studies, clinical applicability of previously presented reference values, and potentially the ability to use retrospective data due to too few timeframes per cardiac cycle and low spatial resolution in images for vessel centerline measurement. This study thereby serves as a mean toward standardization of PWV measurements by CMR.
More specifically, this study showed that: (1) the required timeframes per cardiac cycle for minimum PWV errors was 42 for the aortic arch and 41 for the thoracic aorta in neonates and 39 and 32 for corresponding vessel segments in adolescents; (2) standard coronal overview images cannot replace 3D angiography without risk of intra-individual measurement errors; (3) PWV based on velocity or flow curves does not differ in a young population; (4) time-to-foot with automatic baseline correction has high agreement and low variability and should be used in favor of maximum upslope, whereas time-to-peak cannot be recommended; and 5) automatic baseline correction agrees with manual baseline correction and can be used in subjects without retrograde diastolic flow.

Computer Phantom

This study showed that both shorter aortic lengths as related to age [13] or flow plane acquisition location, and increased PWV as related to age, grade of hypertension, or other cardiovascular diseases [14] risks yielding larger errors at inadequate temporal resolution in both neonates and adolescents. All these factors are thus important to consider in order to ensure sufficient temporal resolution in the individual patient. Pulse wave velocity of the aortic arch can be derived from a single flow plane covering both the ascending aorta and descending aorta immediately after the aortic arch, but requires increased temporal resolution to compensate for the short distance between flow planes. The applicability of low and high temporal resolution acquisitions have been investigated [15, 16] but only Dorniak et al. [6] has of yet dissected the impact of a continuum of timeframes per cardiac cycle and temporal resolutions, despite being addressed as an important aspect already in 2014 [1]. This study presented temporal resolution as the heartrate independent measurement timeframes per cardiac cycle. For comparison between studies and for standardization of clinical application an increased transparency regarding acquired timeframes per cardiac cycle is beneficial.

Pulse Wave Velocity by CMR in Neonates and Adolescents

The current study tested the hypothesis that standard coronal overview images could be used interchangeably with the reference method non-contrast enhanced 3D angiography for measuring accurate blood traveling distance and to calculate PWV in the aortic arch and thoracic aorta. On a group level, a small and likely clinically insignificant difference between 3D angiography and coronal overview was observed. However, when comparing the intra-individual length and corresponding PWV variability for 3D angiography and coronal overview, the variation is both large and unpredictable (Figs. 6 and 10). Differences in slice thickness, slice gap, and number of slices covering the aorta likely explain differences in measured aortic lengths and correspondingly PWV. Therefore, as non-contrast-enhanced 3D angiography can be acquired in only a few minutes it is preferred for accurate PWV calculations also in the young and healthy. The same logic can be applied for the aortic arch where, due to its shorter length and its curvature, accurate centerline length measurements are even more critical. This was also shown in the current study with larger PWV variation in the aortic arch. Retrospective analysis of clinical data sets with only coronal overview images and a single flow acquisition including both the ascending and descending aorta is therefore not recommended, but if used, should only be applied on a group level and with caution.
The current study showed no difference in PWV based on velocity or flow curves. Flow curves are commonly used for PWV by CMR but are affected by diversion of blood. For PWV measured in the aortic arch or thoracic aorta, blood mainly diverge into aortic arch vessels leading to a decline in blood volume of approximately 40% between the ascending and descending aortic flow measurement planes. This can be noted as the difference between the descending and ascending flow curves as shown in Fig. 2. Velocity curves are on the other hand routinely acquired by Doppler ultrasound for applanation tonometry-based PWV. They are less affected by diversion of blood but are instead susceptible to local variations in velocity [17]. Velocity curves are rarely used for PWV by CMR but may be advantageous in more challenging populations due to the more homogeneous curve shapes for transit time estimations. This however remains to be tested.
For baseline correction, automatic correction based on the 80th–95th % segment of the flow curve, i.e., late diastole, agreed with manual correction based on the more variable pre-systolic segment in both neonates and adolescents and for both velocity and flow curves, implying an adequate automatic algorithm. The previously proposed automatic method used the mean of the 62.5th–87.5th % segment of the flow curve [6], i.e., early diastole. Using the diastolic phase for correction may yield false results if extended to populations including patients with diastolic retrograde flow. By instead using a timepoint closer to the systolic upslope, as proposed in the current study, the influence of retrograde diastolic flow may be reduced. This hypothesis was not tested in the current healthy population, and a separate study including patients with retrograde diastolic flow is needed to confirm this hypothesis.
The commonly used transit time methods TTF, maximum upslope, and TTP [1, 610] were compared in the current study, showing that TTF with automatic baseline correction had the narrowest limits of agreement in both neonates and adolescents. This agrees with previous studies showing TTF to be a reproducible method also in other populations [1]. Importantly, neonatal PWV did not differ between methods, whereas in adolescents PWV by TTP was lower than when using TTF and maximum upslope. Time-to-peak not only underestimated PWV, but also risks reporting false negative flow as shown in Fig. 2. This also explains the considerably lower, albeit not statistically significant, PWV value for velocity-based TTP in neonates (1.8 ± 5.4 m/s) as compared to TTF (4.2 ± 1.0 m/s) and maximum upslope (6.1 ± 2.4 m/s). In addition, the current study assessed each method’s robustness, suggesting the use of TTF with automatic baseline correction as the method of choice in neonates and adolescents as it is more robust and less variable than the other tested methods. This will also increase comparability between hospitals and research studies, and use of reference values.
Reference values are available for aortic arch PWV by CMR in adolescents [9, 18]. In both these studies, a sufficient number of timeframes per cardiac cycle was used for flow assessment in the aortic arch, assuming their populations are comparable to the current population in terms of heart rate and aortic arch centerline distance. However, these previous studies used maximum upslope [9] and time-to-half peak [18] as transit time methods, which is important to consider when applying these reference values in relation to the method used locally, as it may lead to wrongly interpreted results.
Whether this suggested standardized method also is accurate compared to invasive measurements remains to be answered. Compared to the current methodological situation, however, the current study presents a reproducible and precise transit time method which is a step forward in increasing comparability and applicability both in clinics and research.

Limitations

The current study did by design not include elderly and patients with cardiovascular disease and the results shown may not be directly transferable to these populations. It may be hypothesized that the differences shown between methods in the current young population are even larger in elderly and in patients with cardiovascular disease. Further, the current study had a reconstruction limit of 35 timeframes per cardiac cycle for flow data acquired in adolescents, which is slightly fewer than that shown to be needed in the adolescent aortic arch, but not thoracic aorta, by the computer phantom. Therefore, the presented adolescent aortic arch PWV values should be taken with caution. However, the method comparisons should not be affected as aortic arch PWV measurements was used only for comparison between use of 3D angiography versus coronal overview images for centerline distance.

Conclusion

This study showed how methodological aspects influence PWV values by CMR in neonates and adolescents. It thereby serves as a mean toward standardization. Phase-contrast flow for assessment of PWV should be acquired with at least 42 and 41 timeframes per cardiac cycle in the neonatal aortic arch and thoracic aorta, respectively, and 39 and 32 timeframes per cardiac cycle for corresponding vessel segments in adolescents. This corresponds to temporal resolutions of 10 ms, 11 ms, 21 ms, and 26 ms, and can be applied to similar populations at their typical heartrates. Adequate number of timeframes and temporal resolution can be accomplished at the scanner by ensuring a sufficient reconstruction limit, which does not affect scan time. Further, 3D angiography should be used for vessel length measurements for accurate PWV, and the transit time method time-to-foot with automatic baseline correction is suggested.

Acknowledgements

Not applicable.

Declarations

Conflict of interest

Dr. Einar Heiberg founded the company Medviso AB, Lund, Sweden, and is the major shareholder of said company and although the software Segment is freely available for research the company also sells a CE-marked and FDA-approved version for commercial use. The remaining authors declare that they have no competing interests.

Ethical Approval

The regional Ethics Review Board (Lund, Sweden) approved the study.
All participants and their guardians when appropriate provided written informed consent before participation in the study.
Not applicable.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Pädiatrie

Kombi-Abonnement

Mit e.Med Pädiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Pädiatrie, den Premium-Inhalten der pädiatrischen Fachzeitschriften, inklusive einer gedruckten Pädiatrie-Zeitschrift Ihrer Wahl.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Wentland AL, Grist TM, Wieben O (2014) Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther 4(2):193–206PubMedPubMedCentral Wentland AL, Grist TM, Wieben O (2014) Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther 4(2):193–206PubMedPubMedCentral
2.
Zurück zum Zitat Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113(5):664–670CrossRef Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113(5):664–670CrossRef
3.
Zurück zum Zitat The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J 31(19):2338–2350CrossRef The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J 31(19):2338–2350CrossRef
4.
Zurück zum Zitat Suever JD, Oshinski J, Rojas-Campos E, Huneycutt D, Cardarelli F, Stillman AE et al (2012) Reproducibility of pulse wave velocity measurements with phase contrast magnetic resonance and applanation tonometry. Int J Cardiovasc Imaging 28(5):1141–1146CrossRef Suever JD, Oshinski J, Rojas-Campos E, Huneycutt D, Cardarelli F, Stillman AE et al (2012) Reproducibility of pulse wave velocity measurements with phase contrast magnetic resonance and applanation tonometry. Int J Cardiovasc Imaging 28(5):1141–1146CrossRef
5.
Zurück zum Zitat Ibrahim E-SH, Johnson KR, Miller AB, Shaffer JM, White RD (2010) Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques. J Cardiovasc Magn Reson. 12(1):26CrossRef Ibrahim E-SH, Johnson KR, Miller AB, Shaffer JM, White RD (2010) Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques. J Cardiovasc Magn Reson. 12(1):26CrossRef
6.
Zurück zum Zitat Dorniak K, Heiberg E, Hellmann M, Rawicz-Zegrzda D, Wesierska M, Galaska R et al (2016) Required temporal resolution for accurate thoracic aortic pulse wave velocity measurements by phase-contrast magnetic resonance imaging and comparison with clinical standard applanation tonometry. BMC Cardiovasc Disord 16(1):110CrossRef Dorniak K, Heiberg E, Hellmann M, Rawicz-Zegrzda D, Wesierska M, Galaska R et al (2016) Required temporal resolution for accurate thoracic aortic pulse wave velocity measurements by phase-contrast magnetic resonance imaging and comparison with clinical standard applanation tonometry. BMC Cardiovasc Disord 16(1):110CrossRef
7.
Zurück zum Zitat Grotenhuis HB, Westenberg JJ, Steendijk P, van der Geest RJ, Ottenkamp J, Bax JJ et al (2009) Validation and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI. J Magn Reson Imaging 30(3):521–526CrossRef Grotenhuis HB, Westenberg JJ, Steendijk P, van der Geest RJ, Ottenkamp J, Bax JJ et al (2009) Validation and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI. J Magn Reson Imaging 30(3):521–526CrossRef
8.
Zurück zum Zitat van Hout MJ, Dekkers IA, Westenberg JJ, Schalij MJ, Widya RL, de Mutsert R et al (2021) Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population. J Cardiovasc Magn Reson 23(1):46CrossRef van Hout MJ, Dekkers IA, Westenberg JJ, Schalij MJ, Widya RL, de Mutsert R et al (2021) Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population. J Cardiovasc Magn Reson 23(1):46CrossRef
9.
Zurück zum Zitat Voges I, Jerosch-Herold M, Hedderich J, Pardun E, Hart C, Gabbert DD et al (2012) Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional study. J Cardiovasc Magn Reson 14(1):77CrossRef Voges I, Jerosch-Herold M, Hedderich J, Pardun E, Hart C, Gabbert DD et al (2012) Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional study. J Cardiovasc Magn Reson 14(1):77CrossRef
10.
Zurück zum Zitat Dogui A, Redheuil A, Lefort M, DeCesare A, Kachenoura N, Herment A et al (2011) Measurement of aortic arch pulse wave velocity in cardiovascular MR: comparison of transit time estimators and description of a new approach. J Magn Reson Imaging 33(6):1321–1329CrossRef Dogui A, Redheuil A, Lefort M, DeCesare A, Kachenoura N, Herment A et al (2011) Measurement of aortic arch pulse wave velocity in cardiovascular MR: comparison of transit time estimators and description of a new approach. J Magn Reson Imaging 33(6):1321–1329CrossRef
11.
Zurück zum Zitat Thurn D, Doyon A, Sözeri B, Bayazit AK, Canpolat N, Duzova A et al (2015) Aortic pulse wave velocity in healthy children and adolescents: reference values for the vicorder device and modifying factors. Am J Hypertens 28(12):1480–1488CrossRef Thurn D, Doyon A, Sözeri B, Bayazit AK, Canpolat N, Duzova A et al (2015) Aortic pulse wave velocity in healthy children and adolescents: reference values for the vicorder device and modifying factors. Am J Hypertens 28(12):1480–1488CrossRef
12.
Zurück zum Zitat Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H (2010) Design and validation of segment–freely available software for cardiovascular image analysis. BMC Med Imaging 10:1CrossRef Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H (2010) Design and validation of segment–freely available software for cardiovascular image analysis. BMC Med Imaging 10:1CrossRef
13.
Zurück zum Zitat Dotter CT, Roberts DJ, Steinberg I (1950) Aortic length: angiocardiographic measurements. Circulation 2(6):915–920CrossRef Dotter CT, Roberts DJ, Steinberg I (1950) Aortic length: angiocardiographic measurements. Circulation 2(6):915–920CrossRef
14.
Zurück zum Zitat Hofman A et al (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J. 31(19):2338–2350CrossRef Hofman A et al (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J. 31(19):2338–2350CrossRef
15.
Zurück zum Zitat Pahlevan NM, Yao T, Chu K, Cole S, Tran T, Wood JC et al (2020) Group delay method for MRI aortic pulse wave velocity measurements in clinical protocols with low temporal resolution: validation in a heterogeneous cohort. Magn Reson Imaging 69:8–15CrossRef Pahlevan NM, Yao T, Chu K, Cole S, Tran T, Wood JC et al (2020) Group delay method for MRI aortic pulse wave velocity measurements in clinical protocols with low temporal resolution: validation in a heterogeneous cohort. Magn Reson Imaging 69:8–15CrossRef
16.
Zurück zum Zitat Peper ES, Strijkers GJ, Gazzola K, Potters WV, Motaal AG, Luirink IK et al (2018) Regional assessment of carotid artery pulse wave velocity using compressed sensing accelerated high temporal resolution 2D CINE phase contrast cardiovascular magnetic resonance. J Cardiovasc Magn Reson 20(1):86CrossRef Peper ES, Strijkers GJ, Gazzola K, Potters WV, Motaal AG, Luirink IK et al (2018) Regional assessment of carotid artery pulse wave velocity using compressed sensing accelerated high temporal resolution 2D CINE phase contrast cardiovascular magnetic resonance. J Cardiovasc Magn Reson 20(1):86CrossRef
17.
Zurück zum Zitat Garcia J, van der Palen RLF, Bollache E, Jarvis K, Rose MJ, Barker AJ et al (2018) Distribution of blood flow velocity in the normal aorta: effect of age and gender. J Magn Reson Imaging 47(2):487–498CrossRef Garcia J, van der Palen RLF, Bollache E, Jarvis K, Rose MJ, Barker AJ et al (2018) Distribution of blood flow velocity in the normal aorta: effect of age and gender. J Magn Reson Imaging 47(2):487–498CrossRef
18.
Zurück zum Zitat Caterini JE, Banks L, Wells GD, Cifra B, Slorach C, McCrindle BW et al (2017) Magnetic resonance imaging reveals elevated aortic pulse wave velocity in obese and overweight adolescents. Clin Obes 7(6):360–367CrossRef Caterini JE, Banks L, Wells GD, Cifra B, Slorach C, McCrindle BW et al (2017) Magnetic resonance imaging reveals elevated aortic pulse wave velocity in obese and overweight adolescents. Clin Obes 7(6):360–367CrossRef
Metadaten
Titel
Pulse Wave Velocity Measurements by Magnetic Resonance Imaging in Neonates and Adolescents: Methodological Aspects and Their Clinical Implications
verfasst von
Simon Lundström
Jonas Liefke
Einar Heiberg
Erik Hedström
Publikationsdatum
09.04.2022
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2022
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-02894-0

Weitere Artikel der Ausgabe 7/2022

Pediatric Cardiology 7/2022 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.